Drug Type siRNA |
Synonyms |
Target |
Mechanism ITFG1 inhibitors(integrin alpha FG-GAP repeat containing 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Diseases | Preclinical | US | Cargene TherapeuticsStartup | 10 Nov 2023 |
Fibrosis, Liver | Preclinical | SG | 26 Sep 2023 | |
Liver Cirrhosis | Preclinical | SG | 26 Sep 2023 |